Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer

被引：0
|
作者：
So Won Oh
Seung-hwan Moon
Do Joon Park
Bo Youn Cho
Kyeong Cheon Jung
Dong Soo Lee
June-Key Chung
机构：
[1] Seoul National University College of Medicine,Department of Nuclear Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Seoul National University College of Medicine,Department of Pathology
[4] Seoul National University Boramae Medical Center,Department of Nuclear Medicine
[5] Seoul National University WCU Graduate School of Convergence Science and Technology,Department of Molecular Medicine and Biopharmaceutical Sciences
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2011年 / 38卷
关键词：
Refractory papillary thyroid cancer; I therapy; Retinoic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1798 / 1805
页数：7
相关论文
共 50 条
  • [1] Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer
    Oh, So Won
    Moon, Seung-hwan
    Park, Do Joon
    Cho, Bo Youn
    Jung, Kyeong Cheon
    Lee, Dong Soo
    Chung, June-Key
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (10) : 1798 - 1805
  • [2] I-131 therapy with retinoic acid in patients with radioiodine-refractory papillary thyroid carcinoma
    Jo, Kyung Sook
    Lee, Su Jin
    Song, Hee Sung
    Yoon, Seok-Ho
    An, Yount-Sil
    Yoon, Joon-Kee
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [3] BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary Thyroid Cancer
    Groener, Jan Benedikt
    Gelen, Debora
    Mogler, Carolin
    Herpel, Esther
    Toth, Csaba
    Kender, Zoltan
    Peichl, Marco
    Haufe, Sabine
    Haberkorn, Uwe
    Sulaj, Alba
    Zemva, Johanna
    Kopf, Stefan
    Nawroth, Peter Paul
    Brune, Maik
    Rudofsky, Gottfried
    [J]. HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 69 - 75
  • [4] The Efficacy of Retinoic Acid in Patients with Radioiodine-Refractory Thyroid Cancer: A Meta-analysis
    Shin, Seunghyeon
    Pak, Kyoungjune
    Kim, Seong-Jang
    Kim, In Joo
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [5] Molecular and Histopathologic Characteristics of Radioiodine-Refractory Papillary Thyroid Cancer
    Choi, Sung-eun
    Pyo, Ju Yeon
    Kim, Ji-seop
    Shin, Eunah
    Hong, Soon W.
    [J]. MODERN PATHOLOGY, 2016, 29 : 147A - 148A
  • [6] Molecular and Histopathologic Characteristics of Radioiodine-Refractory Papillary Thyroid Cancer
    Choi, Sung-eun
    Pyo, Ju Yeon
    Kim, Ji-seop
    Shin, Eunah
    Hong, Soon Won
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 147A - 148A
  • [7] Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer
    Krajewska, Jolanta
    Jarzab, Barbara
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (12): : 1331 - 1340
  • [8] Targeted therapy in patients with radioiodine-refractory differentiated thyroid cancer (DTC)
    Herceg, Davorin
    Herceg, Gordana Horvatic
    [J]. PERIODICUM BIOLOGORUM, 2014, 116 (04) : 399 - 407
  • [9] 131I therapy of thyroid cancer patients
    Reiners, C
    Farahati, J
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 1999, 43 (04): : 324 - 335
  • [10] Preliminary results from a clinical trial combining 131I and external beam radiotherapy for treatment of metastatic radioiodine-refractory thyroid cancer
    Hobbs, R.
    Marsh, I.
    Quon, H.
    Santhanam, P.
    Ladenson, P.
    He, B.
    Kaplin, D.
    Lowe, K.
    Wang, H.
    Sgouros, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S239 - S240
12345